| Title |
Long-term (3-year) neurocognitive effectiveness of antipsychotic medications in first-episode non-affective psychosis: a randomized comparison of haloperidol, olanzapine, and risperidone
|
|---|---|
| Published in |
Psychopharmacology, March 2013
|
| DOI | 10.1007/s00213-013-2994-z |
| Pubmed ID | |
| Authors |
Rosa Ayesa-Arriola, Jose Manuel Rodríguez-Sánchez, Rocío Pérez-Iglesias, Roberto Roiz-Santiáñez, Obdulia Martínez-García, Jose Sánchez-Moreno, Rafael Tabarés-Seisdedos, Jose L. Vázquez-Barquero, Benedicto Crespo-Facorro |
| Abstract |
The initially postulated superior neurocognitive effectiveness of second-generation antipsychotics is currently under debate. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 101 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 2 | 2% |
| Unknown | 99 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 18 | 18% |
| Student > Ph. D. Student | 15 | 15% |
| Student > Bachelor | 10 | 10% |
| Researcher | 10 | 10% |
| Other | 8 | 8% |
| Other | 16 | 16% |
| Unknown | 24 | 24% |
| Readers by discipline | Count | As % |
|---|---|---|
| Psychology | 26 | 26% |
| Medicine and Dentistry | 21 | 21% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 5% |
| Neuroscience | 4 | 4% |
| Agricultural and Biological Sciences | 3 | 3% |
| Other | 9 | 9% |
| Unknown | 33 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 July 2013.
All research outputs
#2,264,114
of 22,699,621 outputs
Outputs from Psychopharmacology
#551
of 5,334 outputs
Outputs of similar age
#19,455
of 193,968 outputs
Outputs of similar age from Psychopharmacology
#8
of 57 outputs
Altmetric has tracked 22,699,621 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,334 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 193,968 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 57 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.